

Hyris to participate to SIBioC 2022 in Genova, presenting Hyris marketplace approach for laboratory medicine
From October 5th to October 7th, Hyris will be present at the SIBioC 2022 in Genova, to present Hyris marketplace approach and Hyris SystemTM disruptive featuresfor laboratory medicine.
Our team will discuss with partners and prospects at Hyris stand First Floor, bar area.
-
Hyris' new onboarding programs support researchers and developers to launch testing kits.
-
Hyris Founder&CEO Stefano Lo Priore interviewed by Carter&Benson
-
Hyris and Singlabs signed a distributorship agreement for Singapore
-
Hyris and P.Intertrade Equipments signed a distributorship agreement for Thai market.
-
Hyris to participate to SIBioC 2022 in Genova, presenting Hyris marketplace approach for laboratory medicine
-
Hyris to participate in SEI 2022 in Leon, hosted by the Sociedad Española de Immunologia
-
Hyris' new T-cell Test is finally available to EU Countries to easily map patients' cellular immunity to SARS-CoV-2
-
Hyris presented Hyris System, its distruptive signature technology, at Analytica 2022 in Munich
-
A new T-cell activation assay based on Hyris technology marks a disruptive approach for the detection of SARS-CoV-2 specific cellular immunity.
-
Hyris and its network want to make pragmatic impact Helping Ukrainian Families